Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models
Emmy D.G. Fleuren(Cancer Institute of New South Wales), Winette T.A. van der Graaf(The Netherlands Cancer Institute)
Cited by 21
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
|Annals of Oncology|2020|145
The role of AXL and the <i>in vitro</i> activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
|Oncotarget|2014|47
Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
|Clinical Cancer Research|2011|42